Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms
Open accessThe DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
Aims/hypothesis Non-alcoholic fatty liver disease (NAFLD) has been associated with the metabolic syndrome. However, it is not clear whether insulin resistance is an independent feature of NAFLD, and it remains to be determined which of the in vivo actions of insulin are impaired in this condition.Methods We performed a two-step (1.5 and 6 pmol min(-1) kg(-1)) euglycaemic insulin clamp coupled with tracer infusion ([6,6-2H2]glucose and [2H5]glycerol) and indirect calorimetry in 12 non-obese, normolipidaemic, normotensive, non-diabetic patients with biopsy-proven NAFLD and six control subjects.Results In NAFLD patients, endogenous glucose production (basal and during the clamp) was normal; however, peripheral glucose disposal was markedly decreased (by 30% and 45% at the low and high insulin doses, respectively, p<0.0001) at higher plasma insulin levels (p=0.05), due to impaired glucose oxidation (p=0.003) and glycogen synthesis (p<0.001). Compared with control subjects, glycerol appearance and lipid oxidation were significantly increased in NAFLD patients in the basal state, and were suppressed by insulin to a lesser extent (p<0.05-0.001). The lag phase of the in vitro copper-catalysed peroxidation of LDL particles was significantly shorter in the patients than in the control subjects (48+/-12 vs 63+/-13 min, p<0.04). Lipid oxidation was significantly related to endogenous glucose production, glucose disposal, the degree of hepatic steatosis, and LDL oxidisability.Conclusions/interpretation Insulin resistance appears to be an intrinsic defect in NAFLD, with the metabolic pattern observed indicating that adipose tissue is an important site.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, many studies have shown an increase in fatty acid oxidation and β-hydroxybutyrate in individuals with MASH compared to those without liver steatosis.,38,39 likely driven by the high fatty acid flux to the liver due to Adipo-IR.”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [39]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance.
National Diabetes Data Group (1979) · Diabetes · doi:10.2337/diab.28.12.1039 · Cited by 4,909
DeFronzo, R. A., & Ferrannini, E. (1991) · Diabetes Care · doi:10.2337/diacare.14.3.173 · Cited by 4,535
Self-citationLudwig, J., Viggiano, T. R., McGill, D. B., & Ott, B. J. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00530-5 · Cited by 2,903
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
Marchesini, G., Bugianesi, E., Forlani, G., Cerrelli, F., Lenzi, M., Manini, R., Natale, S., Vanni, E., Villanova, N., Melchionda, N., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50161 · Cited by 2,679
Self-citation
Cited by
Items 601–700 of 790
Obesity and the Pathogenesis of Nonalcoholic Fatty Liver Disease
Fabbrini, E., & Magkos, F. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1203-2_9 · Cited by 5
Keum, S.-H., Lee, K. M., & Jung, S. P. (2012) · Korean Journal of Health Promotion · Cited by 3
Pathogenesis of Hepatic Steatosis and Fibrosis: Role of Leptin
Magkos, F., Fabbrini, E., & Klein, S. (2014) · Springer eBooks · doi:10.1007/978-3-319-09915-6_8 · Cited by 4
Jeele, M. O. O., Mohamed, H. N., Addow, R. O. B., Hassan, M. O., & Adam, B. A. (2025) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s486956 · Cited by 2
Chen, S. J., Xu, D., Hu, D. K., Hu, P. J., & Huang, T. (2025) · JMIR Medical Informatics · doi:10.2196/75747 · Cited by 2
Non-alcoholic Fatty Liver Disease in Obesity
Ferolla, S. M. (2015) · Springer eBooks · doi:10.1007/978-3-319-19821-7_13 · Cited by 2
Severe insulin resistance: pathologies
Melvin, A., & Stears, A. J. (2017) · Practical Diabetes · doi:10.1002/pdi.2116 · Cited by 2
SPECIFIC FEATURES OF METABOLIC DISORDERS IN MALES AND FEMALES WITH NON-ALCOHOLIC FATTY LIVER DISEASE
Shaabani, S., & Pchelin, I. Y. (2020) · Juvenis scientia · doi:10.32415/jscientia_2020_6_6_18-32 · Cited by 3
Yakovleva, S. V., & Pirogova, I. Y. (2023) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-206-10-50-57 · Cited by 2
Liu, L., Shao, Y., Feng, E., Shao, Z., & Xing, D. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1152747 · Cited by 2
Salim, W., Kamel, M. A. E.-N., Helmy, M. H., & Ghazal, N. A. (2024) · Journal of the Medical Research Institute /Journal of Medical Research Institute · doi:10.21608/jmalexu.2024.279483.1014 · Cited by 2
Wirth, A. G., Hauner, H., Roden, M., Parhofer, K. G., May, M., Engeli, S., Jordan, J., Schulz, R., Schneider, K. T. M., Grote, V. A., et al. (2013) · Springer eBooks · doi:10.1007/978-3-642-22855-1_6 · Cited by 3
The Liver in Metabolic Syndrome
D’Amore, S., Palasciano, G., & Moschetta, A. (2013) · Springer eBooks · doi:10.1007/978-3-319-01008-3_3 · Cited by 3
Meyer, D., & Bodenheimer, H. C. (2009) · Springer eBooks · doi:10.1007/978-0-387-09841-8_35 · Cited by 2
Patomechanisms of hepatic steatosis
Fülöp, P., & Paragh, G. (2010) · Orvosi Hetilap · doi:10.1556/oh.2010.28816 · Cited by 2
Hipertrigliceridemia, esteatosis hepática y riesgo cardiovascular
Brea, Á., Mosquera, D., Mostaza, J. M., Aranda, J. L., Argimón, J., Sanclemente, C., Mateo‐Gállego, R., Almagro, F., Plana, N., & Recarte, C. (2011) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2011.02.003 · Cited by 2
Esteatosis hepática y resistencia a la insulina: ¿qué ocurre primero?
Esteve-Lafuente, E., & Ricart, W. (2006) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/s0214-9168(06)73708-1 · Cited by 3
Insulin Resistance in Egyptian Nonalcoholic Fatty Liver Disease patients
Mohamed, A. A., Shousha, W. G., Shaker, O. G., Mahdy, M., Ibrahim, E., Aal, H. A. A., Hamid, A., Azzat, M., & Shimy, A. E. (2015) · Journal of Advances in Medicine and Medical Research · doi:10.9734/bjmmr/2015/11380 · Cited by 2
Bernsmeier, C., Meyer‐Gerspach, A. C., Blaser, L. S., Jeker, L., Steinert, R. E., Heim, M. H., & Beglinger, C. (2013) · Journal of Hepatology · doi:10.1016/s0168-8278(13)61317-3 · Cited by 2
Down-regulation of hepatic MBOAT7 by hyperinsulinemia favors steatosis development
Meroni, M., Dongiovanni, P., Rametta, R., Bassani, G. A., Badiali, S., Fargion, S. R., Romeo, S., Gatti, S., & Valenti, L. V. C. (2017) · Journal of Hepatology · doi:10.1016/s0168-8278(17)31627-6 · Cited by 2
Ibrahim, R., & Fathy, M. A. (2018) · American Journal of Biomedical Sciences · doi:10.5099/aj180200115 · Cited by 2
Association of insulin resistance and non-alcoholic fatty liver disease
Mishina, E. Е., Mayorov, A. Y., Bogomolov, P., Liusina, E. O., & Bueverov, A. O. (2021) · Diabetes Mellitus · doi:10.14341/dm12234 · Cited by 2
Поширеність неалкогольної жирової хвороби печінки у хворих на предіабет
Agarwal, B., Lamba, B. M. S., Sharma, N., & Tanwar, M. (2021) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.17.1.2021.226427 · Cited by 2
Chen, H.-J., Ko, C., Xu, J.-H., Huang, Y.-C., Wu, J. S., & Shen, S. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/9967910 · Cited by 2
Schindhelm, R. K. (2007) · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) · Cited by 2
The role of Ad-36 and its E4orf-1 protein in modulating glycemic control
Dhurandhar, E. J. (2011) · Louisiana State University · doi:10.31390/gradschool_dissertations.1411 · Cited by 3
Contribution of de novo lipogenesis to the progression of nonalcoholic fatty liver disease
Abdul, M. M. S. (2020) · MOspace Institutional Repository (University of Missouri) · doi:10.32469/10355/81575 · Cited by 2
Nair, M. C., Stanley, L. M., Sivan, G., & Kumar, J. S. (2024) · Egyptian Liver Journal · doi:10.1186/s43066-024-00341-8 · Cited by 1
Genetic Explication of Impaired Insulin Resistance in Genesis of Metabolic Diseases
Soomro, N. I., & Bakhtiar, S. M. (2024) · Journal of Population Therapeutics and Clinical Pharmacology · doi:10.53555//jptcp.v31i6.6988 · Cited by 1
Hou, J., Hou, Y., Yu, C., chen, R., & Wang, J. (2026) · BMC Cardiovascular Disorders · doi:10.1186/s12872-025-05458-1 · Cited by 3
Zhang, Y., Bao, C., Liu, L., Liu, R., Wang, X., Guo, X. H., & Chunjun, L. I. (2026) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s564396 · Cited by 1
van der Spek, A. H., Ritter, M. J., Amano, I., Oliveira, L. S. D., Kaserman, J. E., Cespedes, I. S., Vierling, T., Wilson, A. A., & Hollenberg, A. N. (2026) · Hepatology Communications · doi:10.1097/hc9.0000000000000937 · Cited by 1
Gastaldelli, A., Choi, E., Conde‐Knape, K., Göransson, O., Krook, A., Lehtonen, S. H., Roden, M., Schrauwen, P., Sparks, L. M., & Heni, M. (2026) · Diabetologia · doi:10.1007/s00125-026-06853-9 · Cited by 2
Self-citationYeap, P. M., Lockman, K. A., Elton, R. A., Boyd, M., Hayes, P. C., & Jaap, A. J. (2011) · The British Journal of Diabetes · doi:10.1177/1474651411402630 · Cited by 1
Berlanga, A., Guiu‐Jurado, E., Porras, J. A., Aragonès, G., & Auguet, T. (2015) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2015.03.003 · Cited by 4
Molecular Basis of Liver Disease
Monga, S. P., & Behari, J. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-374419-7.00020-2 · Cited by 2
Metabolic Syndrome, Diabetes and Nonalcoholic Steatohepatitis
Kyrou, I., Haukeland, J. W., Bhala, N. B., & Kumar, S. (2009) · Wiley eBooks · doi:10.1002/9781444307627.ch16 · Cited by 2
Caranti, D. A., Sartório, A., de Piano, A., Tock, L., Lederman, H. M., Minocci, A., Agosti, F., Patrizi, A., de Mello, M. T., Tufik, S., et al. (2010) · e-SPEN the European e-Journal of Clinical Nutrition and Metabolism · doi:10.1016/j.eclnm.2010.06.001 · Cited by 1
Prasad, A. P. V. A. (2013) · IOSR Journal of Dental and Medical Sciences · doi:10.9790/0853-0624448 · Cited by 1
Hepatic Biomarkers in Diabetes as Modulated by Dietary Phytochemicals
Basu, A., Basu, P., & Lyons, T. J. (2016) · Exposure and Health · doi:10.1007/978-94-007-7742-2_35-1 · Cited by 1
Paglialunga, S. (2015) · International Journal of Diabetes and Clinical Research · doi:10.23937/2377-3634/1410037 · Cited by 1
Nabrdalik, K., Pokrzywnicka, P., Nabrdalik-Leśniak, D., Gumprecht, J. J., Kwiendacz, H., & Gumprecht, J. (2017) · Clinical Diabetology · doi:10.5603/dk.2016.0034 · Cited by 1
THE INFLUENCE OF ENVIRONMENTAL FACTORS ON NONALCOHOLIC FATTY LIVER DISEASE AND OBESITY
Kvit, K. B. (2018) · Izdevniecība “Baltija Publishing” eBooks · doi:10.30525/978-9934-571-31-2_6 · Cited by 1
Gut microbiota and nonalcoholic steatohepatitis
Kessoku, T., Imajo, K., Kobayashi, T., Honda, Y., Ogawa, Y., Yoneda, M., Saito, S., & Nakajima, A. (2018) · Folia Pharmacologica Japonica · doi:10.1254/fpj.152.187 · Cited by 1
Current Models of Fatty Liver Disease; New Insights, Therapeutic Targets and Interventions
Jonscher, K. R., & Bruce, K. D. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-12668-1_3 · Cited by 1
Pavlova, Z. S., Moscow, R. F., Иванович, Г. И., & Kamalov, A. A. (2021) · Doctor Ru · doi:10.31550/1727-2378-2021-20-11-62-67 · Cited by 1
Down-regulation of hepatic MBOAT7 by hyperinsulinemia favors steatosis development
Meroni, M., Dongiovanni, P., Longo, M., Rametta, R., Badiali, S., Fargion, S., Romeo, S., Gatti, S., & Valenti, L. V. C. (2018) · Journal of Hepatology · doi:10.1016/s0168-8278(18)30280-0 · Cited by 1
Costentin, C. E., Caussy, C., Valla, D. C., Gourdy, P., Serfaty, L., Petit, J., Leroy, V., Trylesinski, A., & Guerci, B. (2023) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2023.02.002 · Cited by 1
Livzan, M. A., Сергеевна, К. Т., & Syrovenko, M. I. (2024) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-218-10-168-174 · Cited by 1
Systems Biology for Metabolic Disorder and Disease
Sharma, M., & Singh, A. K. (2024) · Springer eBooks · doi:10.1007/978-981-99-9462-5_4 · Cited by 1
Karunaratna, A., & Ekanayake, S. (2024) · The Natural Products Journal · doi:10.2174/0122103155308948240528050738 · Cited by 2
Badran, H. M., Elsabaawy, M., Magdy, M. M., Ghanem, S. E., Said, M., Torky, M. H., & Samir, T. (2024) · The Egyptian Journal of Internal Medicine · doi:10.1186/s43162-024-00353-1 · Cited by 1
α-Lack-SPI Alleviates MASLD in Rats via Regulating Hepatic Lipid Accumulation and Inflammation
Chen, M., Guo, S., Lai, X., Xiao, Q., Wu, X., Pang, J., Pei, L., Gu, Y., Zhang, X., & Yang, L. (2025) · Nutrients · doi:10.3390/nu17182918 · Cited by 1
The Antioxidant, Anti-inflammatory, and Antiapoptotic Effects of Wolfberry in Fatty Liver Disease
Xiao, J., & Tipoe, G. L. (2015) · Springer eBooks · doi:10.1007/978-94-017-9658-3_3 · Cited by 1
Liebe, R., & Keitel, V. (2020) · Der Diabetologe · doi:10.1007/s11428-020-00647-2 · Cited by 1
Shamsabadi, A. A. (2014) · University of Brighton Repository (University of Brighton) · Cited by 1
Cintra, D. E. (2008) · doi:10.47749/t/unicamp.2008.435969 · Cited by 10
Metabolic conditions of fatty liver in non-diabetic obese women
Kantarçeken, B., Çetinkaya, A., Tolun, F. İ., Yerhan, H., Çitirik, Ç., & Büyükbeşe, M. A. (2007) · Journal of Endocrinological Investigation · doi:10.1007/bf03347448 · Cited by 1
PGC-1 alfa como regulador inflamatório na esteato-hepatite não-alcoólica
Barroso, W. A. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2016.tde-06062016-125337 · Cited by 1
Nonalcoholic Fatty Liver Disease
Mishra, P., Rafiq, N., & Younossi, Z. M. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511547416.006 · Cited by 2
The effects of yeast beta-glucan on diabetes, liver cholesterol and fatty liver in rodents.
Feng, F. (2016) · University of Minnesota Digital Conservancy (University of Minnesota) · Cited by 1
Genomic studies in non-alcoholic fatty liver disease
Liu, Y. (2017) · Cited by 1
Guo, C. (2013) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/m2vw2m · Cited by 1
The Liver and Insulin Resistance: The Important Convergence of Endocrinology and Hepatology
Chang, C., Whitt, K. N., Liu, Z., & Caldwell, S. H. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-192-5_13
Effects of Weight Loss on Adipose Tissue, Liver and Heart Metabolism in Humans
Viljanen, A. P. M. (2009) · UTUPub (University of Turku) · Cited by 1
Diabetes and NAFLD: Why is the Connection Important?
Bugianesi, E. (2013) · Wiley eBooks · doi:10.1002/9781118556153.ch6 · Cited by 2
Self-citationInterventions thérapeutiques prometteuses dans un modèle in vivo de stéatohépatite non alcoolique
Haddad, Y. K. (2008) · doi:10.71781/27081 · Cited by 1
Perinatal programming of appetite regulation and metabolic health
Dellschaft, N. S. (2012) · Nottingham ePrints (University of Nottingham)
Gastrointestinal Physiology in Obesity
Miras, A. D., & le Roux, C. W. (2012) · Wiley eBooks · doi:10.1002/9781119962083.ch3
Insulin sensitivity of hepatic glucose and lipid metabolism in animal models of hepatic steatosis
Grefhorst, A. (2006) · University of Groningen research database (University of Groningen / Centre for Information Technology)
LIVER FAT IN THE METABOLIC SYNDROME AND TYPE 2 DIABETES
Kotronen, A. (2008) · Helda - University of Helsinki Institutional Repository · Cited by 1
Glucagon-like peptide-1 in nonalcoholic steatohepatitis
Armstrong, M. J. (2014) · University of Birmingham Institutional Research Archive (University of Birmingham)
Predictors of non-alcoholic fatty liver in a group of non-obese and non-diabetic Iranian adults
Maddah, M., Ahani, N., Hossaini, H., & Karandish, M. (2011) · Mediterranean Journal of Nutrition and Metabolism · doi:10.3233/s12349-011-0073-8
Nealkogol'naya zhirovaya bolezn' pecheni: aktual'nye proekty
Бутрова, С. А., & Eliseeva, A. Y. (2007) · Obesity and metabolism · doi:10.14341/2071-8713-5155
Komshilova, K. A., Troshina, E. A., Бутрова, С. А., Bogomolov, P., & Knyazeva, A. P. (2012) · Obesity and metabolism · doi:10.14341/2071-8713-4968
Lipoprotein Metabolism in Insulin-Resistant States
Avramoglu, R. K., Basciano, H., & Adeli, K. (2006) · Springer eBooks · doi:10.1007/0-387-36279-3_11 · Cited by 1
Pretorius, J. (2012) · SUNScholar (Stellenbosch University)
Nutrition and Alcoholic and Nonalcoholic Fatty Liver Disease: The Significance of Cholesterol
Enjoji, M., Yasutake, K., Kohjima, M., & Nakamuta, M. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-047-2_40
SELECTIVE SEROTONIN REUPTAKE INHIBITORS AND THE RISK OF TYPE 2 DIABETES MELLITUS
Long, N. E. D. (2016) · MacSphere (McMaster University) · doi:10.71548/15716
Behavioral Aspects of Nonalcoholic Fatty Liver Disease: Diet, Causes, and Treatment
Marchesini, G., Nuccitelli, C., Centis, E., Domizio, S. D., Suppini, A., Marzocchi, R., & Grave, R. D. (2011) · Springer eBooks · doi:10.1007/978-0-387-92271-3_119
Choi, S., Joo, M.-H., & Lee, G.-H. (2015) · Asia-pacific Journal of Multimedia services convergent with Art Humanities and Sociology · doi:10.14257/ajmahs.2015.06.29
CLINICAL—LIVER, PANCREAS, AND BILIARY TRACT
Amaro, A., Fabbrini, E., Kars, M., Yue, P., Schechtman, K. B., Schonfeld, G., & Klein, S. (2010)
Tiburcio, T. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.10.2016.tde-11052016-141902
Is insulin resistance the principal cause of NAFLD?
Godsland, I. F., Mehta, S., Forbes, S., Meienberg, F., Yee, M. S., Taylor-Robinson, S. D., & Johnston, D. G. (2016) · Wiley eBooks · doi:10.1002/9781118924938.ch3
Clinical Application of MicroRNAs in Liver Diseases
Song, G., & Vollbrecht, H. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800553-8.00005-6
Evaluation of Eating Behavior and Nutritional Status Using the Nutrition Quotient in Obese Children
Lim, H., Kim, S.-K., Park, Y. H., & Shin, Y. (2016) · The Korean Journal of Obesity · doi:10.7570/kjo.2016.25.4.225
Patrick-Melin, A. J. (2011) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 1
Manchiero, C. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2017.tde-03052017-151729
Loyd, C. (2014) · OhioLink ETD Center (Ohio Library and Information Network)
Verboven (2017) · Research Publications (Maastricht University) · doi:10.26481/dis.20170703kv
Furukawa, Y., Tamura, Y., Takeno, K., Funayama, T., Suzuki, R., Kaga, H., WATANABE, T., Someya, Y., Fujitani, Y., Kawamori, R., et al. (2016) · Juntendō Igaku/Juntendo igaku · doi:10.14789/jmj.62.s149
Karachentsev, Y. I., Gorshunska, M., Tyzhnenko, T. V., Krasova, N. S., Dunaeva, I. P., Gladkih, A. I., Лещенко, Ж., Pochernyaev, A. K., Mishchenko, T., Plohotnichenko, O. O., et al. (2017) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.13.4.2017.106646
Ota, T. (2017) · Springer eBooks · doi:10.1007/978-981-10-4376-5_7
Fiza, B., Sinha, M., Jain, L., & Kasliwal, R. (2017) · Journal of Mahatma Gandhi University of Medical Sciences and Technology · doi:10.5005/jp-journals-10057-0041
Abnormal Glucose Metabolism in Nonalcoholic Fatty Liver Disease
Li, M., Zhang, L., & Ji, G. (2018) · Integrative Gastroenterology and Hepatology · doi:10.18314/igh.v1i1.1210
Alfa, A. W., Abolude, D. S., Abdullahi, S. A., Yaro, C. A., & Salifu, M. (2018) · Asian Journal of Biological Sciences · doi:10.3923/ajbs.2018.186.191
Rôle de la protéine HMGB1 dans la stéatose hépatique associée à l'obésité
Personnaz, J. (2018) · theses.fr (ABES) · doi:10.70675/e2b151abz28ecz470azb40fzf96b17aa368f
Non-alcoholic Fatty Liver in the Pathogenesis of Diabetes
Nogueira, C. A. V., & Leite, N. C. (2019) · Springer eBooks · doi:10.1007/978-3-030-11815-0_15
Metadata
- Authors
- Bugianesi, E., Gastaldelli, A., Vanni, E., Gambino, R., Cassader, M., Baldi, S., Ponti, V., Pagano, G., Ferrannini, E., & Rizzetto, M.
- Affiliations
- Azienda Ospedaliero Universitaria San Giovanni Battista (IT)
- University of Pisa (IT)
- Corresponding author
- Bugianesi, E.
- Venue
- Diabetologia
- Published
- 2005-03-04
- Volume
- 48
- Issue
- 4
- Pages
- 634-642
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W1975388439
- Cited by
- 770
- References
- 63
- Citations by year
- 2026: 19 · 2025: 28 · 2024: 42 · 2023: 48 · 2022: 47 · 2021: 48 · 2020: 51 · 2019: 40 · 2018: 43 · 2017: 46 · 2016: 49 · 2015: 37 · 2014: 40 · 2013: 35 · 2012: 32
- FWCI
- 17.53
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- non-alcoholic fatty liver disease, insulin resistance, glucose oxidation, hepatic glycogen synthesis, lipid oxidation, hepatic steatosis, adipose tissue, non-diabetic patients
- MeSH terms
- Adipose Tissue, Adult, Blood Glucose, Body Composition, C-Peptide, Calorimetry, Indirect, Enzymes, Fasting, Fatty Acids, Nonesterified, Fatty Liver, Glucose, Glycerol, Humans, Insulin, Insulin Resistance, Lipids, Lipoproteins, LDL, Liver, Male, Middle Aged, Oxidation-Reduction, Glucose Clamp Technique, 3-Hydroxybutyric Acid, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.